We have thus far determined the capacities of different ocular tissues such as conjunctiva, anterior uvea and cornea of various species (including monkey and human) to synthesize cyclooxygenase products: prostaglandins (PGs) PGE2, PGF2alpha, PGI2, PGD2 and thromboxane A2, and lipoxygenase products: monohydroxy acids and leukotrienes, from arachidonic acid (AA). In this proposal, we plan to study the roles these products play in the three phases (initiation, maintenance and termination) of ocular inflammation, especially the cellular inflammatory response. Their interaction with each other and other putative mediators such as histamine, bradykinin and chemotactic formylmethionyl polypeptide will be studied as well. In order to investigate the role of AA metabolites as either mediators or modulators, we will study the following using rabbits, cats and rats: 1) correlate the endogenous synthesis and release of PGs, thromboxane and leukotrienes with polymorphonuclear leukocytes (PMNs) infiltration of ocular fluids and tissues and breakdown of the blood-aqueous barrier during three phases of ocular inflammation. Three types of inflammation models will be used: a) paracentesis (no cellular response), b) endotoxin-induced uveitis (all inflammatory responses present) and c) corneal deepithelialization. 2) determine whether or not exogenous PGs and leukotrienes produce one or all inflammatory responses, administered alone or in combination with other autacoids to the normal eye. 3) determine whether or not drugs (steroidal and nonsteroidal), which interfere with AA metabolism at various enzymatic steps, affect one or all inflammatory responses in the three experimentally induced inflammation models outlined above. These studies will also be correlated with measuring the PMN count, leukotriene content and PG levels in tear fluids of volunteers with contact lens allergies. These studies will help in understanding the mechanism of mediators of ocular inflammation and development of new anti- inflammatory drugs.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
7R01EY002861-10
Application #
3257156
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1987-09-01
Project End
1991-11-30
Budget Start
1987-09-01
Budget End
1987-11-30
Support Year
10
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Louisville
Department
Type
Schools of Medicine
DUNS #
City
Louisville
State
KY
Country
United States
Zip Code
40292
Kulkarni, P S; Bhattacherjee, P; Paterson, C A (1994) Dexamethasone inhibits interleukin-1 release in endotoxin-uveitis model. Exp Eye Res 58:637-8
Kulkarni, P; Joshua, I G; Roberts, A M et al. (1994) A novel method to assess reactivities of retinal microcirculation. Microvasc Res 48:39-49
Kulkarni, P S (1994) Steroidal and nonsteroidal drugs in endotoxin-induced uveitis. J Ocul Pharmacol 10:329-34
Kulkarni, P S; Mancino, M (1993) Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp Eye Res 56:275-9
Ohia, E O; Mancino, M; Kulkarni, P S (1992) Effects of steroids and immunosuppressive drugs on endotoxin-uveitis in rabbits. J Ocul Pharmacol 8:295-307
Mancino, M; Ohia, E; Kulkarni, P (1992) A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits. Prostaglandins Leukot Essent Fatty Acids 45:239-43
Kulkarni, P S (1991) The role of endogenous eicosanoids in rabbit-intraocular inflammation. J Ocul Pharmacol 7:227-41
Ohia, E; Kulkarni, P (1991) Corticosteroids and immunosuppressive agents in rabbit heterolamellar corneal transplant model. Agents Actions 34:165-8
Kulkarni, P S (1991) Arachidonic acid metabolism in human and bovine retina. J Ocul Pharmacol 7:135-9
Guo, A; Ohia, E; Xu, J T et al. (1990) Effects of anti-inflammatory and immunosuppressive drugs on the heterolamellar corneal transplantation in rabbits. Curr Eye Res 9:749-57

Showing the most recent 10 out of 20 publications